vs

Side-by-side financial comparison of MIDDLEFIELD BANC CORP (MBCN) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $19.9M, roughly 1.3× MIDDLEFIELD BANC CORP). MIDDLEFIELD BANC CORP runs the higher net margin — 26.7% vs -10.3%, a 37.0% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 18.3%). MIDDLEFIELD BANC CORP produced more free cash flow last quarter ($3.4M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 13.7%).

Star Banc Corporation was a Cincinnati, Ohio-based regional bank holding company that acquired Firstar in 1998 and took the Firstar name; the merged bank acquired U.S. Bancorp in 2001 and took the U.S. Bancorp name. The company can trace its origins back to 1863 when it was first founded as the First National Bank of Cincinnati.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

MBCN vs NPCE — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.3× larger
NPCE
$26.6M
$19.9M
MBCN
Growing faster (revenue YoY)
NPCE
NPCE
+5.6% gap
NPCE
23.9%
18.3%
MBCN
Higher net margin
MBCN
MBCN
37.0% more per $
MBCN
26.7%
-10.3%
NPCE
More free cash flow
MBCN
MBCN
$3.0M more FCF
MBCN
$3.4M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
13.7%
MBCN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
MBCN
MBCN
NPCE
NPCE
Revenue
$19.9M
$26.6M
Net Profit
$5.3M
$-2.7M
Gross Margin
77.4%
Operating Margin
32.2%
-6.6%
Net Margin
26.7%
-10.3%
Revenue YoY
18.3%
23.9%
Net Profit YoY
127.4%
48.0%
EPS (diluted)
$0.65
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MBCN
MBCN
NPCE
NPCE
Q4 25
$26.6M
Q3 25
$19.9M
$27.4M
Q2 25
$20.5M
$23.5M
Q1 25
$18.0M
$22.5M
Q4 24
$17.5M
$21.5M
Q3 24
$16.8M
$21.1M
Q2 24
$16.8M
$19.3M
Q1 24
$16.8M
$18.1M
Net Profit
MBCN
MBCN
NPCE
NPCE
Q4 25
$-2.7M
Q3 25
$5.3M
$-3.5M
Q2 25
$6.2M
$-8.7M
Q1 25
$4.8M
$-6.6M
Q4 24
$4.8M
$-5.3M
Q3 24
$2.3M
$-5.5M
Q2 24
$4.2M
$-7.5M
Q1 24
$4.2M
$-8.9M
Gross Margin
MBCN
MBCN
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
MBCN
MBCN
NPCE
NPCE
Q4 25
-6.6%
Q3 25
32.2%
-9.5%
Q2 25
35.9%
-29.0%
Q1 25
31.9%
-22.9%
Q4 24
33.4%
-17.0%
Q3 24
16.1%
-20.1%
Q2 24
28.8%
-32.4%
Q1 24
29.4%
-41.6%
Net Margin
MBCN
MBCN
NPCE
NPCE
Q4 25
-10.3%
Q3 25
26.7%
-12.8%
Q2 25
30.0%
-36.8%
Q1 25
26.8%
-29.3%
Q4 24
27.8%
-24.5%
Q3 24
13.9%
-25.9%
Q2 24
24.7%
-39.0%
Q1 24
24.9%
-49.2%
EPS (diluted)
MBCN
MBCN
NPCE
NPCE
Q4 25
$-0.08
Q3 25
$0.65
$-0.11
Q2 25
$0.76
$-0.26
Q1 25
$0.60
$-0.21
Q4 24
$0.60
$-0.16
Q3 24
$0.29
$-0.19
Q2 24
$0.52
$-0.26
Q1 24
$0.51
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MBCN
MBCN
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$61.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$224.1M
$19.0M
Total Assets
$2.0B
$105.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MBCN
MBCN
NPCE
NPCE
Q4 25
$61.1M
Q3 25
$60.0M
Q2 25
$62.1M
Q1 25
$66.3M
Q4 24
$52.8M
Q3 24
$56.8M
Q2 24
$55.5M
Q1 24
$58.9M
Stockholders' Equity
MBCN
MBCN
NPCE
NPCE
Q4 25
$19.0M
Q3 25
$224.1M
$18.5M
Q2 25
$216.1M
$19.4M
Q1 25
$213.8M
$24.3M
Q4 24
$210.6M
$8.0M
Q3 24
$210.7M
$9.8M
Q2 24
$206.8M
$9.9M
Q1 24
$205.6M
$14.3M
Total Assets
MBCN
MBCN
NPCE
NPCE
Q4 25
$105.6M
Q3 25
$2.0B
$107.3M
Q2 25
$1.9B
$106.1M
Q1 25
$1.9B
$110.2M
Q4 24
$1.9B
$94.6M
Q3 24
$1.9B
$96.3M
Q2 24
$1.8B
$94.4M
Q1 24
$1.8B
$98.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MBCN
MBCN
NPCE
NPCE
Operating Cash FlowLast quarter
$4.8M
$506.0K
Free Cash FlowOCF − Capex
$3.4M
$409.0K
FCF MarginFCF / Revenue
17.0%
1.5%
Capex IntensityCapex / Revenue
7.2%
0.4%
Cash ConversionOCF / Net Profit
0.91×
TTM Free Cash FlowTrailing 4 quarters
$32.0M
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MBCN
MBCN
NPCE
NPCE
Q4 25
$506.0K
Q3 25
$4.8M
$-1.9M
Q2 25
$4.8M
$-2.1M
Q1 25
$8.0M
$-7.5M
Q4 24
$17.5M
$-4.8M
Q3 24
$6.0M
$-1.7M
Q2 24
$3.4M
$-3.9M
Q1 24
$5.4M
$-7.5M
Free Cash Flow
MBCN
MBCN
NPCE
NPCE
Q4 25
$409.0K
Q3 25
$3.4M
$-2.0M
Q2 25
$4.2M
$-2.3M
Q1 25
$7.7M
$-7.5M
Q4 24
$16.7M
$-4.8M
Q3 24
$5.8M
$-1.8M
Q2 24
$3.3M
$-4.0M
Q1 24
$5.3M
$-7.6M
FCF Margin
MBCN
MBCN
NPCE
NPCE
Q4 25
1.5%
Q3 25
17.0%
-7.2%
Q2 25
20.5%
-9.6%
Q1 25
42.9%
-33.4%
Q4 24
95.6%
-22.5%
Q3 24
34.7%
-8.7%
Q2 24
19.3%
-20.6%
Q1 24
31.9%
-42.1%
Capex Intensity
MBCN
MBCN
NPCE
NPCE
Q4 25
0.4%
Q3 25
7.2%
0.1%
Q2 25
3.0%
0.7%
Q1 25
1.5%
0.2%
Q4 24
4.4%
0.2%
Q3 24
1.0%
0.5%
Q2 24
0.6%
0.3%
Q1 24
0.5%
0.6%
Cash Conversion
MBCN
MBCN
NPCE
NPCE
Q4 25
Q3 25
0.91×
Q2 25
0.78×
Q1 25
1.66×
Q4 24
3.60×
Q3 24
2.57×
Q2 24
0.81×
Q1 24
1.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons